Rationale and techniques of intra-operative hyperthermic intraperitoneal chemotherapy

Cancer Treatment Reviews
A J WitkampF A N Zoetmulder

Abstract

In recent years surgical cytoreduction followed by intra-operative hyperthermic intraperitoneal chemotherapy (HIPEC) was introduced as treatment modality in patients with peritoneal surface malignancy. In the current review the rational for this approach, the prerequisites and the different techniques used are discussed. A literature search through PubMed was performed. Pharmacokinetic studies have shown an important dose advantage for intraperitoneal versus intravenous application. Hyperthermia enhances the penetration of cytostatic drugs into tumour tissue and also shows synergism with various cytostatic drugs. The penetration depth of drugs into tissue is limited, therefore HIPEC can only be effective in patients with minimal residual disease after (aggressive) surgery. HIPEC can be conducted in various ways, without clear proven advantage of one method over the others. Local complications after this combined treatment approach are mainly surgery related. Intraperitoneal chemotherapy may cause systemic toxicity, dependent on the drug used. In randomised studies cytoreductive surgery followed by HIPEC has proven its value in the prevention of peritoneal dissemination in gastric cancer. Phase II data on HIPEC in peritoneal car...Continue Reading

References

Jan 1, 1991·The Journal of Surgical Research·U FumagalliM Montorsi
Jan 1, 1995·Annals of Surgery·P H Sugarbaker
Aug 1, 1997·European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology·D EliasP Lasser
Jun 13, 1998·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·P J van de VaartA C Begg
May 14, 1999·Archives of Surgery·D TsiftsisD Michaloudis
Dec 22, 1999·Acta Oncologica·O DahlO Mella
Jun 15, 2000·Cancer Chemotherapy and Pharmacology·M O NicolettoA Corsini
Jun 22, 2000·Journal of Surgical Oncology·F CavaliereR Cavaliere
Dec 31, 1955·Journal of the American Medical Association·A S WEISBERGERJ P STORAASLI

❮ Previous
Next ❯

Citations

Jul 30, 2009·Annals of Surgical Oncology·Terence C ChuaDavid L Morris
Jul 31, 2013·Annals of Surgical Oncology·Anke M J KuijpersVic J Verwaal
Dec 12, 2012·Cancer Management and Research·Daniel L ChanTerence C Chua
Nov 11, 2010·Future Oncology·Ze LuJessie L-S Au
Nov 6, 2008·Expert Review of Anticancer Therapy·Perry ShenEdward A Levine
Dec 23, 2011·World Journal of Surgical Oncology·Carolin D DuhrJoerg O W Pelz
Feb 11, 2016·International Journal of Hyperthermia : the Official Journal of European Society for Hyperthermic Oncology, North American Hyperthermia Group·Grace Hwei Ching TanMelissa Ching Ching Teo
Aug 1, 2012·Expert Review of Anticancer Therapy·Eelco de Bree, C William Helm
Apr 28, 2010·Expert Review of Medical Devices·Dewei Jia, Jing Liu
Nov 26, 2015·Journal of Surgical Oncology·Hironori ShiozakiJaffer A Ajani
May 7, 2013·Current Opinion in Solid State & Materials Science·Bo Sun, Yoon Yeo
Sep 17, 2015·European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology·A M KuijpersV J Verwaal
Aug 19, 2015·European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology·N BouhadjariH Keita
Jan 11, 2011·European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology·D J EversV J Verwaal
Dec 1, 2009·Critical Care Clinics·Sanam Ahmed, John M Oropello
Nov 17, 2009·Advanced Drug Delivery Reviews·Paul CherukuriSteven A Curley
Mar 22, 2016·European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology·N BouhadjariH Keïta
Jun 15, 2015·Journal of Controlled Release : Official Journal of the Controlled Release Society·Kazuki N SugaharaAndrew M Lowy
Oct 22, 2008·International Journal of Pharmaceutics·W BouquetC Vervaet
Jul 2, 2008·Current Problems in Surgery·Robert M SmeenkVictor J Verwaal
Apr 21, 2007·Urology·Ardavan AkhavanRonald Benoit
Dec 22, 2006·Cancer Treatment Reviews·R M SmeenkF A N Zoetmulder
Aug 29, 2003·The British Journal of Surgery·F RovielloUNKNOWN Italian Research Group for Gastric Cancer
Aug 30, 2008·Journal of Surgical Oncology·Vic J VerwaalMarcello Deraco
Apr 6, 2011·Journal of Surgical Oncology·Daphne HompesVictor Verwaal
Jan 12, 2005·European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology·E de BreeD D Tsiftsis
Nov 18, 2005·European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology·E de BreeF A N Zoetmulder

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.